Androgenic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group: Subcutaneous injection of the solution containing growth factors including fibroblast growth factors, insulin growth factors, and essential amino acids obtained fro
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with androgenetic alopecia Age 18 to 50 years Male Norwood-Hamilton grade II to V
Exclusion criteria
Exclusion criteria: Patients with two or more diagnoses of hair loss Treatment of hair loss in the last 3 months Patients undergoing radiotherapy and chemotherapy Immunosuppressive drugs or corticosteroids during the previous 4 weeks Uncontrolled chronic diseases Malignancy Coagulopathy or the use of anticoagulants History of autoimmune diseases HBV, HCV and HIV infections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: zero and 2 weeks, 1, 2, 4 and 6 months after first injection. Method of measurement: History and clinical examination based on Common Terminology Criteria for Adverse Events criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frontal and vertex hair density. Timepoint: 1, 2, 4, and 6 months after the first injection. Method of measurement: Digital videotrichoscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Bajouri
Tehran University of Medical Sciences
Outcome results
None listed